Long-Term Outcomes after Slow Low-Dose Oral Immunotherapy for Cow’s Milk
International Archives of Allergy and Immunology · 2024
DOI: 10.1159/000542796 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Archives of Allergy and Immunology, 2024. Verfasst von Yoshito Matsuo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy, Allergy and Immunology Center, Aichi Children's Health and Medical Center, Aichi, Japan, sbqxg502@yahoo.co.jp. Hauptthemen laut MEDLINE: Milk Hypersensitivity, Desensitization, Immunologic, Allergens. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Introduction
We previously reported the result of slow low-dose oral immunotherapy (SLOIT), which is a 1-year severity-stratified low-dose OIT for severe cow’s milk (CM) allergy (CMA) (threshold dose ≤287 mg of cumulative CM protein at the entry oral food challenge [OFC]). After completing the SLOIT protocol (exit OFC to cumulative 287 mg of CM protein), the participants were instructed to gradually increase the amount of CM, roughly doubling the increasing pace, if they could consume it symptom free for 2–3 months (SLOIT plus). This study evaluated the long-term outcomes of SLOIT and identified the factors associated with these outcomes.
Methods
The subjects were 23 children who completed the SLOIT protocol and proceeded with the SLOIT-plus instructions. The proportion of subjects who were desensitized to the full dose (FD; 200 mL of CM) was evaluated. Additionally, factors associated with FD 3 years after SLOIT (FD group) were analyzed. The allergic symptoms provoked in the OFC were quantified using the total score (TS) of the Anaphylaxis Scoring Aichi (ASCA), and the overall severity was expressed as TS/Pro (TS/cumulative protein dosage).
Results
The number of subjects who were desensitized to FD within 12, 24, and 36 months was 0 (0%), 3 (13%), and 8 (35%), respectively. The FD group exhibited a larger decrease in TS/Pro, IgE specific to CM, and casein after the SLOIT protocol.
Conclusion
A third of the children with severe CMA were desensitized to FD within 36 months after SLOIT. A better response to the 1-year SLOIT protocol was associated with better long-term outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Allergy, Allergy and Immunology Center, Aichi Children's Health and Medical Center, Aichi, Japan, sbqxg502@yahoo.co.jp.
- Department of Allergy, Allergy and Immunology Center, Aichi Children's Health and Medical Center, Aichi, Japan.
Zitieren
APA
Matsuo, Y., Sugiura, S., Masukane, S., Tanaka, F., Makino, A., Kitamura, K., Matsui, T., Takasato, Y., & Ito, K. (2024). Long-Term Outcomes after Slow Low-Dose Oral Immunotherapy for Cow’s Milk. International Archives of Allergy and Immunology. https://doi.org/10.1159/000542796
Vancouver
Matsuo Y, Sugiura S, Masukane S, Tanaka F, Makino A, Kitamura K, et al. Long-Term Outcomes after Slow Low-Dose Oral Immunotherapy for Cow’s Milk. International Archives of Allergy and Immunology. 2024. doi:10.1159/000542796
BibTeX
@article{Matsuo2024,
author = {Matsuo, Yoshito and Sugiura, Shiro and Masukane, Seiya and Tanaka, Fumi and Makino, Atsushi and Kitamura, Katsumasa and Matsui, Teruaki and Takasato, Yoshihiro and Ito, Komei},
title = {Long-Term Outcomes after Slow Low-Dose Oral Immunotherapy for Cow’s Milk},
journal = {International Archives of Allergy and Immunology},
year = {2024},
doi = {10.1159/000542796}
}
EUVIMED